After 7 years of research and test marketing, natural medical product company MediKane is launching NutriKane D a proven health product that will improve the lives of Australians and people around the world who suffer from elevated blood sugar levels, which is a major problem for people living with diabetes.
This all-new product, that is supported with high quality scientific and clinical evidence is a breakthrough in the food as medicine space and will be launched on Australia Day Friday 26 January 2018.
NutriKane D is a safe, natural, concentrated medical food that comes in an easy to use sachet dose. NutriKane D contains all of the types of dietary fibres and a wide range of essential micronutrients that have been shown to not only aid the maintenance of the microbiome but also reduce inflammation and ultimately help control blood sugar levels. Research has shown that up to 90% of all diseases can be traced in some way back to the gut and health of the microbiome.
In other good news, recent changes to investment laws mean that each and every one us now has the opportunity to invest in this groundbreaking Australian product.
MediKane Holdings Ltd is currently preparing a crowd-sourced funding (CSF) offer document and undergoing checks with Enable Funding (AFSL: 502802) before undertaking a CSF capital raise. Potential investors in MediKane Holdings Ltd should consider the CSF offer document and the general risk warning (when both are available) at www.enablefunding.com before deciding to invest.
For product information and sales visit: www.nutrikane.com.au For Media enquiries Amanda Buckworth, AB Publicity
E: firstname.lastname@example.org M: 0413 949 140